Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9516 |
High Similarity |
NPD3027 |
Phase 3 |
0.9127 |
High Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.9048 |
High Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8992 |
High Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8992 |
High Similarity |
NPD1613 |
Approved |
0.875 |
High Similarity |
NPD3018 |
Phase 2 |
0.8583 |
High Similarity |
NPD2982 |
Phase 2 |
0.8583 |
High Similarity |
NPD228 |
Approved |
0.8583 |
High Similarity |
NPD2983 |
Phase 2 |
0.8504 |
High Similarity |
NPD2981 |
Phase 2 |
0.8443 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.8397 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.8295 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.8281 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.8271 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.8254 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.8151 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8115 |
Intermediate Similarity |
NPD3022 |
Approved |
0.8115 |
Intermediate Similarity |
NPD3021 |
Approved |
0.8095 |
Intermediate Similarity |
NPD2801 |
Approved |
0.806 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.8058 |
Intermediate Similarity |
NPD3540 |
Phase 1 |
0.8015 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7987 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7986 |
Intermediate Similarity |
NPD3539 |
Phase 1 |
0.7973 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7883 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7879 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7847 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7836 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7833 |
Intermediate Similarity |
NPD846 |
Approved |
0.7833 |
Intermediate Similarity |
NPD940 |
Approved |
0.7778 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7763 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7755 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7754 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7754 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7754 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7752 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.775 |
Intermediate Similarity |
NPD1242 |
Phase 1 |
0.7748 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7742 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7742 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7742 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.774 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7737 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7737 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7727 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7724 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7708 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.768 |
Intermediate Similarity |
NPD4750 |
Phase 3 |
0.7667 |
Intermediate Similarity |
NPD37 |
Approved |
0.7655 |
Intermediate Similarity |
NPD7124 |
Phase 2 |
0.7626 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7613 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.76 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7597 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7594 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7584 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.7582 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7569 |
Intermediate Similarity |
NPD3060 |
Approved |
0.7566 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7554 |
Intermediate Similarity |
NPD2674 |
Phase 3 |
0.7548 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7547 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7535 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7533 |
Intermediate Similarity |
NPD4678 |
Approved |
0.7533 |
Intermediate Similarity |
NPD4675 |
Approved |
0.7532 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7518 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7516 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7516 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7516 |
Intermediate Similarity |
NPD4965 |
Approved |
0.75 |
Intermediate Similarity |
NPD1357 |
Approved |
0.75 |
Intermediate Similarity |
NPD943 |
Approved |
0.75 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7484 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7483 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7468 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7468 |
Intermediate Similarity |
NPD4055 |
Discovery |
0.7466 |
Intermediate Similarity |
NPD2219 |
Phase 1 |
0.7465 |
Intermediate Similarity |
NPD6111 |
Discontinued |
0.7463 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7462 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7452 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.745 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7448 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7448 |
Intermediate Similarity |
NPD5177 |
Phase 3 |
0.7438 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7432 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7432 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7431 |
Intermediate Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.7431 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7426 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7426 |
Intermediate Similarity |
NPD2922 |
Phase 1 |
0.7421 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7417 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7417 |
Intermediate Similarity |
NPD2860 |
Approved |
0.7417 |
Intermediate Similarity |
NPD2859 |
Approved |
0.7386 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7383 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7381 |
Intermediate Similarity |
NPD290 |
Approved |
0.7377 |
Intermediate Similarity |
NPD3020 |
Approved |
0.7365 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7365 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7361 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7361 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7361 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7357 |
Intermediate Similarity |
NPD5109 |
Approved |
0.7357 |
Intermediate Similarity |
NPD3144 |
Approved |
0.7357 |
Intermediate Similarity |
NPD5111 |
Phase 2 |
0.7357 |
Intermediate Similarity |
NPD5110 |
Phase 2 |
0.7357 |
Intermediate Similarity |
NPD3145 |
Approved |
0.7333 |
Intermediate Similarity |
NPD2933 |
Approved |
0.7333 |
Intermediate Similarity |
NPD2934 |
Approved |
0.7333 |
Intermediate Similarity |
NPD9296 |
Approved |
0.7329 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7329 |
Intermediate Similarity |
NPD4237 |
Approved |
0.7329 |
Intermediate Similarity |
NPD4236 |
Phase 3 |
0.7324 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7319 |
Intermediate Similarity |
NPD6584 |
Phase 3 |
0.7317 |
Intermediate Similarity |
NPD8053 |
Approved |
0.7317 |
Intermediate Similarity |
NPD8054 |
Approved |
0.7313 |
Intermediate Similarity |
NPD4626 |
Approved |
0.731 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.731 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7286 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7284 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7279 |
Intermediate Similarity |
NPD3892 |
Phase 2 |
0.7279 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7267 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7266 |
Intermediate Similarity |
NPD5451 |
Approved |
0.7266 |
Intermediate Similarity |
NPD9494 |
Approved |
0.726 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.726 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7255 |
Intermediate Similarity |
NPD5090 |
Approved |
0.7255 |
Intermediate Similarity |
NPD5089 |
Approved |
0.7254 |
Intermediate Similarity |
NPD2238 |
Phase 2 |
0.7248 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7244 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7239 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7237 |
Intermediate Similarity |
NPD6055 |
Clinical (unspecified phase) |
0.7234 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7226 |
Intermediate Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7222 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7222 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7214 |
Intermediate Similarity |
NPD5752 |
Clinical (unspecified phase) |
0.7211 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7203 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7203 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7203 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.72 |
Intermediate Similarity |
NPD4123 |
Phase 3 |
0.7195 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7195 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7185 |
Intermediate Similarity |
NPD6516 |
Phase 2 |
0.7185 |
Intermediate Similarity |
NPD5846 |
Approved |
0.7179 |
Intermediate Similarity |
NPD6788 |
Approved |
0.7178 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7172 |
Intermediate Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.7172 |
Intermediate Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.7165 |
Intermediate Similarity |
NPD968 |
Approved |
0.7162 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7161 |
Intermediate Similarity |
NPD2978 |
Approved |
0.7161 |
Intermediate Similarity |
NPD2977 |
Approved |
0.7161 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7153 |
Intermediate Similarity |
NPD2232 |
Approved |
0.7153 |
Intermediate Similarity |
NPD2233 |
Approved |
0.7153 |
Intermediate Similarity |
NPD4097 |
Suspended |
0.7153 |
Intermediate Similarity |
NPD2230 |
Approved |
0.7152 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7152 |
Intermediate Similarity |
NPD5261 |
Clinical (unspecified phase) |
0.7134 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7132 |
Intermediate Similarity |
NPD3847 |
Discontinued |
0.7131 |
Intermediate Similarity |
NPD844 |
Approved |
0.7124 |
Intermediate Similarity |
NPD7261 |
Clinical (unspecified phase) |
0.7123 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7114 |
Intermediate Similarity |
NPD2677 |
Approved |
0.7114 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7113 |
Intermediate Similarity |
NPD5718 |
Phase 2 |
0.7103 |
Intermediate Similarity |
NPD6895 |
Approved |
0.7103 |
Intermediate Similarity |
NPD6896 |
Approved |
0.7101 |
Intermediate Similarity |
NPD6583 |
Phase 3 |
0.7101 |
Intermediate Similarity |
NPD6582 |
Phase 2 |
0.7099 |
Intermediate Similarity |
NPD5535 |
Approved |
0.7095 |
Intermediate Similarity |
NPD4162 |
Approved |
0.7091 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7086 |
Intermediate Similarity |
NPD1424 |
Approved |
0.7086 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7078 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7075 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7075 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7075 |
Intermediate Similarity |
NPD1375 |
Discontinued |
0.7068 |
Intermediate Similarity |
NPD709 |
Approved |
0.7059 |
Intermediate Similarity |
NPD2668 |
Approved |
0.7059 |
Intermediate Similarity |
NPD2667 |
Approved |
0.7055 |
Intermediate Similarity |
NPD5960 |
Phase 3 |
0.7055 |
Intermediate Similarity |
NPD5588 |
Approved |
0.7051 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.705
|
Intermediate Similarity |
NPD6696 |
Suspended |